Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine as Adjuvant to Bupivacaine in Pediatric TAP Block
NCT04539314Completed
- Sponsor
- Minia University
- Start
- Aug 2019
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of dexmedetomidine in postoperative pain (3 arms), sponsored by Minia University. Primary endpoint: Quality of analgesia (FLACC scale) at 24 hours. Started Aug 2019; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04539314.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04539314.